Effects of glucagon‐like peptide‐1 receptor agonists on cardiovascular risk: a meta‐analysis of randomized clinical trials
Matteo Monami(Azienda Ospedaliero-Universitaria Careggi), Edoardo Mannucci(University of Florence), Ilaria Dicembrini(Azienda Ospedaliero-Universitaria Careggi), Irene Fiordelli(Azienda Ospedaliero-Universitaria Careggi), Clara Nardini(Azienda Ospedaliero-Universitaria Careggi)
Cited by 172
Related Papers
Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study
|European Journal of Endocrinology|2011|434
Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis
|European Journal of Endocrinology|2013|406
Testosterone and Metabolic Syndrome: A Meta-Analysis Study
|The Journal of Sexual Medicine|2010|395
Type 2 diabetes mellitus and testosterone: a meta-analysis study
|International Journal of Andrology|2010|369
Effect of metformin on cardiovascular events and mortality: a meta‐analysis of randomized clinical trials
|Diabetes Obesity and Metabolism|2010|364